From October 1, 2022 to December 29, 2022, the company has repurchased 120,000 shares, representing 2% for KRW 3,418.04 million. With this, the company has completed the repurchase of 120,000 shares, representing 2% for KRW 3,418.04 million under the buyback announced on September 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,950 KRW | -0.18% |
|
-0.89% | +0.72% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.72% | 12Cr | |
+20.76% | 4.38TCr | |
+28.00% | 2.28TCr | |
+20.25% | 1.56TCr | |
+18.82% | 1.43TCr | |
+55.83% | 1.3TCr | |
-0.05% | 678.76Cr | |
-12.70% | 641.27Cr | |
-8.87% | 572.55Cr | |
+14.65% | 568.66Cr |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.